Evidence map›Paper›PMID 26819546›Full record

ReviewBiomarker insights2015

MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations.

Jennifer Louten, Michael Beach, Kristina Palermino, Maria Weeks, Gabrielle Holenstein

Abstract readReview
In one paragraph

Review in Biomarker insights, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Circulating miRNAs: Potential diagnostic role for coronavirus disease 2019 (COVID-19).Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jennifer LoutenDepartment of Molecular and Cellular Biology, Kennesaw State University, Kennesaw, GA, USA.
Michael BeachDepartment of Molecular and Cellular Biology, Kennesaw State University, Kennesaw, GA, USA.
Kristina PalerminoDepartment of Molecular and Cellular Biology, Kennesaw State University, Kennesaw, GA, USA.
Maria WeeksDepartment of Molecular and Cellular Biology, Kennesaw State University, Kennesaw, GA, USA.
Gabrielle HolensteinDepartment of Molecular and Cellular Biology, Kennesaw State University, Kennesaw, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are short sequences of noncoding single-stranded RNAs that exhibit inhibitory effects on complementary target mRNAs. Recently, it has been discovered that certain viruses express their own miRNAs, while other viruses activate the transcription of cellular miRNAs for their own benefit. This review summarizes the viral and/or cellular miRNAs that are transcribed during infection, with a focus on the biomarker and therapeutic potential of miRNAs (or their antagomirs). Several human viruses of clinical importance are discussed, namely, herpesviruses, polyomaviruses, hepatitis B virus, hepatitis C virus, human papillomavirus, and human immunodeficiency virus.

Indexed as

biomarkerhepatitisherpesvirusmicroRNAvirus

Identifiers

PMID26819546
PMCPMC4718089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.